Cargando…
Ex vivo Manufactured Neutrophils for Treatment of Neutropenia—A Process Economic Evaluation
Neutropenia is a common side-effect of acute myeloid leukemia (AML) chemotherapy characterized by a critical drop in neutrophil blood concentration. Neutropenic patients are prone to infections, experience poorer clinical outcomes, and require expensive medical care. Although transfusions of donor n...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405517/ https://www.ncbi.nlm.nih.gov/pubmed/30881955 http://dx.doi.org/10.3389/fmed.2019.00021 |